Image
Loading
Image
29 March, 2022

New Molecular Assay – Signatera ™

The sooner you find out, the faster you can act. Early Detection of residual disease at molecular level before relapse. New Molecular Assay – Signatera ™ Early Detection of residual […]

Read More
Image
16 March, 2022

Lower risk of cancer with less meat consumption

CHAPTER 1o MEAT Lower risk of cancer with less meat consumption Vegetarians have a 14% lower chance of developing cancer than carnivores, according to a large study that links meat-eating […]

Read More
Image
28 February, 2022

World Rare Disease Day

A rare condition is defined as one that affects less than 1 in 2,000 of the general population. Rare diseases include rare cancers, such as childhood cancers, and some other […]

Read More
Image
18 February, 2022

The first patient in the UK to have the Cancer Vaccine.

Graham Booth has been treated for cancer four times, his doctors have informed him that if the cancer returns, which is likely, they will no longer have a choice. He […]

Read More
Image
15 February, 2022

February 15 World Childhood Cancer Day

What are the suspicious symptoms that will lead to the possible diagnosis of childhood cancer? – Fever without a clear source of infection. – Mass (tumor) in any part of […]

Read More
Image
1 February, 2022

Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients

According to a new Italian scientific study published in the Journal of Thoracic Oncology of the International Association for the Study of Lung Cancer, patients with lung cancer who quit […]

Read More
Image
18 January, 2022

”Igia Pano Apo Ola” – Personalized pharmacotherapy based on human DNA.

The TV show “Igia Pano Apo Ola” was in Genekor’s Laboratory to meet the iGEM Patras 2021, the student team who won the Bronze medal in the 2021 GiANT JAMBOREE […]

Read More
Image
30 December, 2021

Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients

The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to present […]

Read More
Image
10 December, 2021

San Antonio Breast Cancer Symposium 2021

The poster of the study conducted by Genekor’s Scientific Team “Different Copy Number Variations (CNVs) account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing” […]

Read More